307 related articles for article (PubMed ID: 3724304)
1. Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers. II. Evaluation of rabbits as qualitative animal model.
Bansinath M; Ghosh SS; Shukla VK; Chopra KS; Mathur VS
Methods Find Exp Clin Pharmacol; 1986 May; 8(5):303-7. PubMed ID: 3724304
[TBL] [Abstract][Full Text] [Related]
2. Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers.
Bansinath M; Ghosh SS; Shafiqa A; Shukla VK; Chopra KS; Mathur VS
Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):30-3. PubMed ID: 3957487
[TBL] [Abstract][Full Text] [Related]
3. Effects of 2-hydroxypropyl-beta-cyclodextrin on pharmacokinetics of digoxin in rabbits and humans.
He ZG; Li YS; Zhang TH; Tang X; Zhao C; Zhang RH
Pharmazie; 2004 Mar; 59(3):200-2. PubMed ID: 15074593
[TBL] [Abstract][Full Text] [Related]
4. [Enhanced bioavailability of digoxin from silica matrix formulations (author's transl)].
Flasch H; Asmussen B; Heinz N
Arzneimittelforschung; 1978; 28(2):326-30. PubMed ID: 205226
[TBL] [Abstract][Full Text] [Related]
5. Single dose bioavailability of two different digoxin tablets.
Jonkman JH; Gusdorf CF; van der Boon WJ; Grasmeijer G; Jedema JN
Arzneimittelforschung; 1987 Jan; 37(1):62-5. PubMed ID: 3566859
[TBL] [Abstract][Full Text] [Related]
6. Absolute bioavailability of digoxin tablets.
Beveridge T; Nüesch E; Ohnhaus EE
Arzneimittelforschung; 1978; 28(4):701-3. PubMed ID: 581950
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the bioavailability of digoxin in capsule, tablet, and solution taken orally with intravenous digoxin.
Binnion PF
J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):461-7. PubMed ID: 977789
[TBL] [Abstract][Full Text] [Related]
8. Study on the absolute bioavailability of quinine and theophylline from tablets after single dose oral administration as compared to intravenous infusion in healthy male non-smoking volunteers.
Fuder H; Herzog R; Vaupel W; Wetzelsberger N; Lücker PW
Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):651-60. PubMed ID: 7746027
[TBL] [Abstract][Full Text] [Related]
9. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
[TBL] [Abstract][Full Text] [Related]
10. Digoxin tablets--a review of the bioavailability problems.
Sim SK
Am J Hosp Pharm; 1976 Jan; 33(1):44-8. PubMed ID: 1266866
[TBL] [Abstract][Full Text] [Related]
11. [Comparative bioavailability of three pharmaceutical forms of digoxin].
Thebault J; Lucas A; d'Athis P; Tillement JP
Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):144-7. PubMed ID: 576592
[TBL] [Abstract][Full Text] [Related]
12. Bioavailability of digoxin from tablets. III. Availability of digoxin in man from preparations with different dissolution rate.
Nyberg L; Andersson KE; Bertler A
Acta Pharm Suec; 1974 Nov; 11(5):471-92. PubMed ID: 4440505
[No Abstract] [Full Text] [Related]
13. A cross-over study of oral and intravenous administration of theophylline in male volunteers. Absolute bioavailability of theophylline tablets.
Kaumeier HS; Kehrhahn OH; Neugebauer G; Schuppan D; Schwarz JA; Staib AH
Arzneimittelforschung; 1984; 34(1):92-5. PubMed ID: 6538428
[TBL] [Abstract][Full Text] [Related]
14. Comparative bioavailability and in vitro in vivo correlation of two sustained release brands of theophylline: tablets and pellets.
Tulain U; Ur-Rahman N
Pak J Pharm Sci; 2008 Apr; 21(2):131-8. PubMed ID: 18390443
[TBL] [Abstract][Full Text] [Related]
15. Comparative bioavailability study of two tablet formulations of digoxin.
Aboul-Enein HY; Abou-Basha LI; Wahman LF
J Immunoassay Immunochem; 2004; 25(2):125-33. PubMed ID: 15162916
[TBL] [Abstract][Full Text] [Related]
16. Non-equivalence of digoxin tablets.
Reissell P; Manninen V; Ojala K; Karjalainen J
Ann Clin Res; 1974; 6(0):suppl 11:4-8. PubMed ID: 4853359
[No Abstract] [Full Text] [Related]
17. [Absolute bioavailability of beta-acetyldigoxin from tablets and drops in healthy subjects].
Dreyer M; Dammann HG; Endell W; Rudolph M; Iven H
Arzneimittelforschung; 1992 Mar; 42(3):303-6. PubMed ID: 1497688
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability of digoxin from tablets. II. Radioimmunoassay and disposition pharmacokinetics of digoxin after intravenous administration.
Nyberg L; Andersson KE; Bertler A
Acta Pharm Suec; 1974 Nov; 11(5):459-70. PubMed ID: 4440504
[No Abstract] [Full Text] [Related]
19. Pharmacokinetics, bioavailability, and dosage regimens of digoxin in dogs.
Button C; Gross DR; Johnston JT; Yakatan GJ
Am J Vet Res; 1980 Aug; 41(8):1230-7. PubMed ID: 7447117
[TBL] [Abstract][Full Text] [Related]
20. Digoxin bioavailability: formulations and rates of infusions.
Marcus FI; Dickerson J; Pippin S; Stafford M; Bressler R
Clin Pharmacol Ther; 1976 Sep; 20(3):253-9. PubMed ID: 954346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
